Newsletter | November 16, 2021

11.16.21 -- Repurposed Cancer Treatments Could Be Potential Alzheimer's Drugs

Industry Insights
Align Your CMC Strategy With Clinical Path Requirements And Timeline

Manufacturers must understand the challenges associated with creating a CMC strategy in today’s crowded and diverse market and the expertise and resources needed to successfully execute it.

Cell Line Development: Accelerating Process Optimization By Combining Ambr 15 Cell Culture With Octet Titer Measurements

Introducing analytical technology into the cell culture process development workflow can greatly speed up the time to results. This platform is an analytical instrument that can easily be implemented in cell line development labs to facilitate rapid determination of product yield.

7 Things To Know When Selecting An Electronic Lab Notebook

Electronic lab notebooks (ELNs) are one of the primary scientific informatics solutions for helping scientists design, execute, analyze and report on experiments—but selecting the right ELN can be a challenge.

New Alternatives For Low- And High-Throughput RNA Isolation/Extraction Offer Simplicity, Cost Savings, And Availability

This paper demonstrates that extraction column spin devices can efficiently isolate and purify high-quality RNA and genomic DNA with yields and qualities similar to devices found in commercial kits.

Learn About Affinity Chromatography Using Tagged Protein Purification

Affinity tags can help you simplify your protein purification and protect your outcomes. Choosing the right tag is essential to getting the purity, solubility, and protein quality your application needs. With our handbook, you can learn how to prepare a recombinant protein in the quantity and quality you need.

Navigating Bioconjugate Development: A Q&A With Lonza Experts

Iwan Bertholjotti, director of commercial bioconjugate development and Dr. Bernhard Stump, head of bioconjugate development, discuss complexity and uncertainty in the bioconjugates market.

Identifying And Mitigating Potential For Immunogenicity, Immunotoxicity

Explore the challenges of assessing the immunosafety profile when moving a drug candidate to FIH studies, including key considerations and pitfalls to avoid along the way.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.